Trucept Valuation
| TREP Stock | USD 0.05 0 2.60% |
Trucept seems to be fairly valued based on Macroaxis valuation methodology. Our model measures the value of Trucept from inspecting the company fundamentals such as Operating Margin of (0.01) %, return on equity of 0.0036, and Shares Outstanding of 50.26 M as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Trucept's price fluctuation is out of control at this time. Calculation of the real value of Trucept is based on 3 months time horizon. Increasing Trucept's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Trucept's intrinsic value may or may not be the same as its current market price of 0.05, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0487 | Real 0.0492 | Hype 0.05 |
The intrinsic value of Trucept's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Trucept's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Trucept helps investors to forecast how Trucept pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Trucept more accurately as focusing exclusively on Trucept's fundamentals will not take into account other important factors: Trucept Total Value Analysis
Trucept is at this time forecasted to have valuation of 221.15 K with market capitalization of 2.77 M, debt of 1.13 M, and cash on hands of 78.09 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Trucept fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
221.15 K | 2.77 M | 1.13 M | 78.09 K |
Trucept Investor Information
The company recorded a loss per share of 0.16. Trucept had not issued any dividends in recent years. The entity had 1:250 split on the 31st of March 2009. Based on the key indicators related to Trucept's liquidity, profitability, solvency, and operating efficiency, Trucept is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Trucept Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Trucept connotes not a very effective usage of assets in March.Trucept Profitability Analysis
The company reported the previous year's revenue of 20 M. Net Income was 1.65 M with profit before overhead, payroll, taxes, and interest of 9.31 M.About Trucept Valuation
The pink sheet valuation mechanism determines Trucept's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Trucept based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Trucept. We calculate exposure to Trucept's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Trucept's related companies.Trucept, Inc., through its subsidiaries, provides business services in the United States. The company was formerly known as Smart-Tek Solutions, Inc. and changed its name to Trucept, Inc. in January 2013. Trucept operates under Staffing Employment Services classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Trucept's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Trucept's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Trucept's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Trucept's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Trucept's revenue streams: Identify Trucept's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Trucept's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Trucept's growth potential: Evaluate Trucept's management, business model, and growth potential.
- Determine Trucept's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Trucept's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Trucept Growth Indicators
Investing in growth stocks can be very risky. If the company such as Trucept does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Quarterly Earnings Growth Y O Y | -0.809 | |
| Retained Earnings | 9.7 M |
Additional Tools for Trucept Pink Sheet Analysis
When running Trucept's price analysis, check to measure Trucept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trucept is operating at the current time. Most of Trucept's value examination focuses on studying past and present price action to predict the probability of Trucept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trucept's price. Additionally, you may evaluate how the addition of Trucept to your portfolios can decrease your overall portfolio volatility.